kabutan

Medical Data Vision Co.,Ltd.(3902) Summary

3902
TSE Prime
Medical Data Vision Co.,Ltd.
462
JPY
+9
(+1.99%)
Dec 12, 3:30 pm JST
2.96
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
64.8
PBR
6.11
Yield
1.95%
Margin Trading Ratio
9.86
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
458 JPY 2.94 USD
Previous Close Dec 11
453 JPY 2.90 USD
High Dec 12, 9:15 am
462 JPY 2.97 USD
Low Dec 12, 10:11 am
456 JPY 2.92 USD
Volume
130,700
Trading Value
0.06B JPY 0.39M USD
VWAP
459.45 JPY 2.95 USD
Minimum Trading Value
46,200 JPY 296 USD
Market Cap
0.02T JPY 0.12B USD
Number of Trades
199
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Slightly High
1-Year Average
421
1-Year High Feb 12, 2025
1,575
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 224,300 1,041,900 4.65
Nov 28, 2025 223,700 1,012,000 4.52
Nov 21, 2025 214,300 1,019,000 4.76
Nov 14, 2025 219,600 1,069,800 4.87
Nov 7, 2025 227,600 1,110,400 4.88
Company Profile
Medical Data Vision Co., Ltd. provides a "Data Network" for hospital and medical information, as well as data utilization services of medical information for pharmaceutical companies.
Sector
Information & Communication
Medical Data Vision Co., Ltd. offers management support systems for hospitals and clinics while simultaneously collecting and storing medical and health information with consent from medical institutions and patients. By analyzing and utilizing this data, the company contributes to improving the quality of healthcare. Their main services include "MDV Act," a cloud-based hospital management improvement application; "EVE," a DPC (Diagnosis Procedure Combination) analysis benchmark system; and "Medical Code," a management issue resolution support system. Through the provision of these systems, the company has built a hospital network, which forms the basis for constructing a large-scale medical database. Utilizing this database, Medical Data Vision offers "MDV analyzer," a drug prescription analysis tool, and ad hoc survey services for pharmaceutical companies and research institutions. Additionally, the company has developed "Karteco," a PHR (Personal Health Record) service for patients.